Jan P. Witte, MD

This account is inactive. M.D. #Hematology and #Oncology. Raised @ChariteBerlin. Supporting #yeswecancer. @[email protected]

[Jan P. Witte, MD @JanPWitte1]

I had a the great honor and privilege to be invited to give my expert opinion on medical #cannabis legislation during the public hearing at the German Parliament (#Bundestag).
https://t.co/dhThsGSyBE

[Jan P. Witte, MD @JanPWitte1]

I haven’t been on Twitter for a while and would like to inform you that I won’t use Twitter anymore for a while. You will find me on other networks.

Good bye!

[Jan P. Witte, MD @JanPWitte1]

@AaronGoodman33 Great book!

[Jan P. Witte, MD @JanPWitte1]

Do you know pediatric oncology colleague how can help me with this pediatric oncology question?

@WorldSIOP @ASPHO_hq @MDAndersonNews @DanaFarber @StJude @ASCO @myESMO @SickKidsNews @GreatOrmondSt @AlderHey @ChildrensPhila @love_snuh @UCIP_HNJ @westmeadkids

[Jan P. Witte, MD @JanPWitte1]

Oncology friends, can you help me with this one, or with someone who can: #Palifermin during treatment of #nasopharyngeal #carcinoma?- 14yr old patient with treatment delaying #mucositis after induction with cisplatin +#5FU. Palifermin for 2nd cycle? #oncotwitter #Medtwitter …

[Jan P. Witte, MD @JanPWitte1]

What I would like to know: would you see a greater risk through the unknown reaction of #palifermin and a nasopharyngeal carcinoma or the risk of massive treatment delay even before combined Chemo+Radiation.

Please reach out via messenger if you do not want to make it public.

[Jan P. Witte, MD @JanPWitte1]

Oncology friends, can you help me with this one, or with someone who can: #Palifermin during treatment of #nasopharyngeal #carcinoma?- 14yr old patient with treatment delaying #mucositis after induction with cisplatin +#5FU. Palifermin for 2nd cycle? #oncotwitter #Medtwitter …

[Jan P. Witte, MD @JanPWitte1]

Heute vor 7 Jahren kam dieser sehr gute Artikel von @Fried_julia über den Preis von Immuntherapien in der Onkologie heraus. Der Artikel ist immer noch brand aktuell - nur 4337 Euro für eine Therapie schockt heute niemanden mehr.
https://t.co/uINBJb37NZ

[Jan P. Witte, MD @JanPWitte1]

@BrownHospMed @DrCindyCooper Practical advice, if you come across a young patient with work out induced #Rhabdomyolysis: you need to address Doping! I have seen two cases at the #ER over the years, both connected to steroid doping.

[Jan P. Witte, MD @JanPWitte1]

@Innov_Medicine Beautiful

[Jan P. Witte, MD @JanPWitte1]

421 km of #berlinmarathon2022 and a new work mission.

@drreddys @NimbusHealthGER
#BerlinMarathon #Cannabinoid #research #drugdevelopment

https://t.co/2Tm5EVpwhW

[Jan P. Witte, MD @JanPWitte1]

@TC3consortium @ICRS_Society @BahlGeorge @uoftmedicine @researchuoft Well deserved!

[Jan P. Witte, MD @JanPWitte1]

https://t.co/pLLWNfXxQt

[Jan P. Witte, MD @JanPWitte1]

#ICRS2022Galway: Great contributions from the @Lambert_Usyd team. Congratulations to @AnastasiaSuraev! Winner of the @ICRS_Society's best predoctoral oral presentation prize. See you all at #ICRS2023Toronto
@EA_Cairns @iainsmcgregor @AdamAmetovski @eric_sparkes @JonathonCArnold

[Jan P. Witte, MD @JanPWitte1]

@ThomasAgoritsas @BMJ_Open @DenaZera @JasonWBusse @ArnavAgarwalMD @McMasterU @bmj_latest Thanks for pointing out the #RapidRec page on #Cannabis again. Very helful for physicians! I also find the graphics from the #MagicApp useful for patients to understand probabilities better.

https://t.co/HrFU51gC9r

[Jan P. Witte, MD @JanPWitte1]

Fresh off @BMJ_Open's press: Systematic #review on Long-term and serious harms of medical #cannabis & #cannabinoids for #ChronicPain by @DenaZera, @JasonWBusse, @ArnavAgarwalMD & @ThomasAgoritsas from @McMasterU.

https://t.co/U4j2bjgJeK

[Jan P. Witte, MD @JanPWitte1]

Thanks to @AaronGoodman33 for pointing this out.

Thanks to @tmprowell for summarizing it with this beautiful quote from #MayaAngelou.

[Tatiana Prowell, MD @tmprowell]

@AaronGoodman33 Reactive arthritis

(For #MedStudentTwitter #MedEd, this reactive arthritis was formerly called Reiter’s syndrome: https://t.co/BimH3gVmlT.)

[Jan P. Witte, MD @JanPWitte1]

.. Our study identified an association between more liberal policies for natural cannabis and declines in reported #synthetic #cannabinoid poisonings. This finding suggests a potential effect of policy change on substance use behaviours with longterm #publichealth implications."

[Jan P. Witte, MD @JanPWitte1]

Important research for #cannabis policy makers:

"Adoption of permissive cannabis law was associated with significant reductions in reported #synthetic #cannabinoid exposures."

#LegalizeIt @BdB_SD_Blienert @Karl_Lauterbach

https://t.co/i76hVk6rnP

[Jan P. Witte, MD @JanPWitte1]

I keep on saying this over & over again:
#syntheticdrugs in #Cannabis from the #illicitmarket is a common problem no one is talking about. 5F-MDMB-PICA was found by @UniFreiburg in a sample.
We need systematic testing to find out how big the problem is!
https://t.co/fefnruIe9q

[Jan P. Witte, MD @JanPWitte1]

Conclusion: "The gradual reduction of prohibitions against plant-based #cannabis offers an opportunity to study use of cannabis and powerful synthetic analogues that may have been used as natural cannabis substitutes. /...

[Jan P. Witte, MD @JanPWitte1]

#Cannabidiol was found to be safe & reduced anxiety severity by 42.6% in young people with treatment-resistant #anxiety. an open-label trial just published in @PsychiatristCNS.
Great work by @maximusberger, Emily Li, @iainsmcgregor, @PatMcGorry et al

@orygen_aus @headspace_aus

[Jan P. Witte, MD @JanPWitte1]

Thanks to the authors for making their Data available in a public, #OpenAccess repository: #bestPractice in #Science.

#ScienceTwitter
https://t.co/aeQjewGpO5

[Jan P. Witte, MD @JanPWitte1]

Conclusions: There is very low certainty evidence that adverse events are common among people living with #ChronicPain who use medical #cannabis or #cannabinoids, but that few patients experience serious adverse events.